Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Original Article

J. Larkin, V. Chiarion-Sileni, R. Gonzalez, J.-J. Grob, P. Rutkowski, C.D. Lao, C.L. Cowey, D. Schadendorf, J. Wagstaff, R. Dummer, P.F. Ferrucci, M. Smylie, D. Hogg, A. Hill, I. Márquez-Rodas, J. Haanen, M. Guidoboni, M. Maio, P. Schöffski, M.S. Carlino, C. Lebbé, G. McArthur, P.A. Ascierto, G.A. Daniels, G.V. Long, L. Bastholt, J.I. Rizzo, A. Balogh, A. Moshyk, F.S. Hodi, and J.D. Wolchok

N Engl J Med 2019;381:1535-1546

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/16/2019
Course expires: 
10/17/2021

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, October 17, 2021 - 11:59pm.